Inmediate Feeding Tolerance in Acute Pancreatitis
Launched by HOSPITAL CENTRAL "DR. IGNACIO MORONES PRIETO" · Nov 23, 2017
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
The investigators included patients 15 - 85 years old, any sex. Diagnosis of mild acute pancreatitis according to the Ranson, APACHE II and BISAP.
Signed infromed consent to participate in the study. All participants had a hepatic and biliary ultrasound to determine the biliary etiology.
The investigators excluded patients with pancreatitis of nonbiliary etiology, pregnant, severe pancreatitis, cholangitis or choledocholithiasis demonstrated during the hospital stay or with other comorbidities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 15 years.
- • Patients with a diagnosis of mild acute pancreatitis biliary.
- • Patients who agree to enter the protocol.
- Exclusion Criteria:
- • Patients managed at another institution.
- • Patients with a diagnosis of pancreatitis of non-biliary etiology.
- • Patients with heart disease or lung disease.
- • Patients with organic failure.
- • Patients with pregnancy.
- • Patients with cholangitis.
Trial Officials
Juan F Hernandez
Study Chair
Postgraduate office at UASLP
About Hospital Central "Dr. Ignacio Morones Prieto"
Hospital Central "Dr. Ignacio Morones Prieto" is a leading medical institution dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence in patient care, the hospital serves as a pivotal center for conducting clinical trials that aim to evaluate new treatments and improve therapeutic outcomes. Equipped with state-of-the-art facilities and a team of experienced healthcare professionals, the hospital fosters an environment of collaboration and scientific inquiry, ensuring rigorous adherence to ethical standards and regulatory compliance. By participating in cutting-edge research, Hospital Central "Dr. Ignacio Morones Prieto" contributes significantly to the advancement of medical knowledge and the enhancement of patient health within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials